Michael J. Fox Foundation awards grant for Exenatide research
Following encouraging results recently published in the Journal of Clinical Investigation describing the progress of a cohort of patients treated with Exenatide for their Parkinson’s disease (PD), The Michael J.…
Stem Cell Programming Advance
Scientists based at the University of Edinburgh’s MRC Centre for Regenerative Medicine (CRM) and Anne Rowling Clinic have taken a vital step forward in understanding how cells from skin tissue…
Exenatide may be disease-modifying for PD
Exenatide is a type 2 diabetes treatment that has been shown to have neuroprotective/neurorestorative properties in preclinical models of neurodegeneration. A new study by Aviles-Olmos et al published in the…
Brain-Imaging Technique Can Help Diagnose Movement Disorders
A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson’s disease. Science…
New Animal Model Provides Important Clues On Mechanisms of Parkinson’s Disease
In a post dated 24 May, Science Daily reports that scientists at the German Centre for Neurodegenerative Diseases (DZNE) in Bonn have developed a novel experimental model that reproduces for…
Important advance in disease-modifying therapy
A team of German researchers led by Jens Wagner, Sergey Ryazanov, Andrei Leonov, Johannes Levin and Song Shi, reports an important breakthrough in the search for disease-modifying therapy for Parkinson’s…